辛伐他汀诱导Graves眼病眼眶成纤维细胞铁死亡
本研究探讨铁死亡是否参与辛伐他汀对Graves眼病(GO)的保护作用。GO眼眶成纤维细胞(GO-OFs)对erastin诱导的铁死亡抵抗;辛伐他汀处理后GO-OFs活力与脂肪生成显著降低,活性氧、脂质过氧化及铁死亡标志物ACLS4升高。结果表明铁死亡在GO发病中起重要作用,辛伐他汀可能通过诱导铁死亡发挥治疗作用。
要点
- GO-OFs对erastin诱导的铁死亡具有抵抗性。
- 辛伐他汀降低GO-OFs活力和脂肪生成。
- 辛伐他汀升高GO-OFs的ROS、脂质过氧化和ACLS4水平。
核心结论
- 铁死亡在Graves眼病发病中起重要作用。
- 辛伐他汀可能诱导铁死亡,提示该药可作为Graves眼病的新型治疗药物。
研究设计与样本
- 体外研究,比较GO眼眶成纤维细胞(GO-OFs)与对照眼眶成纤维细胞(control-OFs)。
主要发现
- GO-OFs对erastin诱导的铁死亡具有抵抗性。
- 辛伐他汀处理后GO-OFs活力和脂肪生成显著降低。
- 辛伐他汀处理后GO-OFs的ROS、脂质过氧化和铁死亡标志物ACLS4水平升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Graves' ophthalmopathy (GO), the most common extrathyroidal manifestation of Graves' disease, is disabling and disfiguring. Recent studies have shown that statins have a protective effect on individuals with GO. Statins were reported to trigger ferroptosis in some disorders, but little is known about whether statins protect against GO via ferroptosis. The aim of this study was to explore whether ferroptosis is involved in the protective effect of simvastatin on GO. METHODS: GO-OFs, which are orbital fibroblasts (OFs) derived from individuals with GO, were analyzed for lipogenesis by RT-qPCR and Red Oil O staining posttreatment with simvastatin. CCK-8 assays, flow cytometric analysis, and transmission electron microscopy (TEM) were used to compare the sensitivity of GO-OFs and control-OFs to erastin-induced ferroptosis. The ferroptosis levels in the GO-OFs were evaluated by measuring cell viability, reactive oxygen species (ROS) levels, and lipid peroxidation levels and performing TEM analysis after treatment with simvastatin and Fer-1. RESULTS: The GO-OFs were resistant to erastin-induced ferroptosis. The viability and lipogenesis of the GO-OFs were significantly decreased, while the levels of ROS, lipid peroxidation, and the ferroptosis marker ACLS4 were increased upon treatment with simvastatin. CONCLUSIONS: Our study indicated that ferroptosis plays an important role in the pathogenesis of GO and that simvastatin may induce ferroptosis, suggesting that this drug could serve as a novel therapeutic agent for GO.
引用
- Wang L, Li Y, Niu T, et al. Simvastatin-Induced Ferroptosis in Orbital Fibroblasts in Graves' Ophthalmopathy. Invest Ophthalmol Vis Sci. 2025. PMID: 39854011. doi:10.1167/iovs.66.1.56
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。